NUVL Chart
See on advanced chart >
About
Nuvalent, Inc. was incorporated under the laws of the State of Delaware on January 25, 2017. They are a preclinical stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. They focus their discovery efforts...
Read More
- HighlightA biotech company developing novel small molecule kinase inhibitors for cancer treatment
- ExchangeNASDAQ
- Listing Date07/29/2021
- Established Date01/25/2017
- Full-time Employees92
- AddressOne Broadway 14th Floor Cambridge MA 02142
- Tel1-857-3577000
- Website
- Fiscal Year End Date12/31
- Security TypeCommon Stock
Industry
Biotechnology